Equities

Adherium Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Adherium Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.005
  • Today's Change0.00 / 0.00%
  • Shares traded2.00m
  • 1 Year change-58.33%
  • Beta1.8173
Data delayed at least 20 minutes, as of Feb 09 2026 02:52 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Adherium Limited is a digital health company. The Company provides integrated digital health solutions and connected respiratory medical devices. The Company’s Hailie platform solution provides clinicians, healthcare providers and patients access to remotely monitor medication usage parameters and adherence, supporting reimbursement for qualifying patient management. The Hailie solution includes a suite of integration tools to enable the capture and sharing of health data through mobile and desktop apps, software development kit and application programming interface (API) integration tools, and the Company’s own broad range of sensors connected to respiratory medications. The Company’s Hailie solution is designed to provide visibility to healthcare providers of medication use history to better understand patterns in patient respiratory disease. Its Hailie Smartinhaler sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication.

  • Revenue in AUD (TTM)2.01m
  • Net income in AUD-12.68m
  • Incorporated2015
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Uscom Ltd2.61m-3.30m3.12m11.00------1.20-0.0179-0.01790.0143-0.00020.62320.48837.20---78.80-38.49-153.15-49.4086.6585.94-126.46-69.180.6614-42.941.02---30.78-5.85-59.19--12.51--
Universal Biosensors, Inc.5.95m-17.46m4.17m97.00--0.5895--0.7012-0.0586-0.05860.020.02380.24810.9995.62---72.76-29.82-88.98-37.4026.7349.79-293.32-249.731.13--0.034---5.28-1.85-111.22---47.46--
Global Health Limited8.70m-866.63k4.29m49.00------0.4935-0.0149-0.01490.1494-0.06382.94--9.24---29.29-41.02---189.5976.9277.94-9.96-32.95---7.90----0.35586.8133.95------
Osteopore Ltd2.85m-3.36m4.76m--------1.67-0.0502-0.05020.0253-0.00230.65121.933.37---76.99-66.84-224.39-96.4078.2075.04-118.22-193.611.11-8.171.34--24.5946.3431.19---28.77--
Pathkey.AI Ltd42.15k-1.45m10.93m3.00------259.25-0.0068-0.00680.0002-0.00110.0912--1.31---313.07-178.95---421.77-----3,434.73-351.33---22.292.87---93.01-46.3753.75---41.50--
Adheris Health Ltd62.99m-63.32m14.01m100.00--13.11--0.2225-0.1093-0.10390.10640.00170.9089--6.04---91.35-28.29-174.13-46.3052.2555.43-100.51-29.62---5.000.9431---35.9841.59-2,608.61--27.40--
Adherium Ltd2.01m-12.68m15.45m--------7.70-0.0174-0.01740.0026-0.00530.29960.79591.40---189.21-108.61-1,408.29-166.7432.2149.74-631.44-430.390.1893-89.24-----12.37-2.10-24.01---18.98--
ReNerve Ltd271.71k-3.73m15.81m----3.15--58.19-0.0262-0.02620.00190.0365----------------90.05---1,374.23--6.10-34.480.00--53.19---25.09------
Memphasys Ltd3.70k-5.04m16.12m24.00--2.88--4,357.68-0.0022-0.00220.000.00210.00030.35150.0037---42.63-26.29-85.43-37.53-961.89---136,191.30-16,363.590.1934-6.140.5451---93.83--6.19---23.54--
Resonance Health Ltd11.16m-1.73m20.42m18.00--2.11--1.83-0.0038-0.00380.02450.02040.5848--3.82---9.08-4.17-12.91-4.98-----15.53-9.03---6.570.2882--26.7824.65-1,123.59--19.97--
Control Bionics Ltd7.04m-6.11m23.07m----3.06--3.28-0.0232-0.02320.02610.01830.81584.993.35---70.78-48.07-99.30-55.8071.1468.24-86.77-98.271.08-33.300.0733--16.7616.36-3.30--7.93--
Data as of Feb 09 2026. Currency figures normalised to Adherium Ltd's reporting currency: Australian Dollar AUD

Institutional shareholders

23.62%Per cent of shares held by top holders
HolderShares% Held
Regal Funds Management Pty Ltd.as of 29 Dec 2025482.35m19.21%
FIL Investment Management (Hong Kong) Ltd.as of 31 Dec 202591.68m3.65%
FIL Pensions Managementas of 30 Jun 202516.86m0.67%
UBS Switzerland AG (Investment Management)as of 23 Jul 20252.25m0.09%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.